Results 131 to 140 of about 147,775 (297)

Stress cardiomyopathy as a cardiovascular manifestation of COVID-19. [PDF]

Glob Cardiol Sci Pract, 2023
Abdullah KM, Bakir M, Greenberg D, Almasri E.   +3 more
europepmc   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Takotsubo Cardiomyopathy: An Exploration of the Intersection Between Stress, Coronary Dysfunction, and Cardiac Outcomes

Reviews in Cardiovascular Medicine
Takotsubo syndrome (TTS) is an acute, reversible form of left ventricular dysfunction, typically triggered by emotional or physical stress. The hallmark feature is reversible regional wall motion abnormality extending beyond a single coronary ...
Davide Rossi, Silvio Saraullo, Roberta Magnano, Laura Pezzi, Alberto D'Alleva, Fabrizio Ricci, Claudio Scollo, Mario Di Marino, Eugenio Genovesi, Piergiusto Vitulli, Daniele Forlani, Giulia Renda, Sabina Gallina, Massimo Di Marco   +13 more
doaj   +1 more source

Nightmare as a trigger for stress cardiomyopathy. [PDF]

Cardiol J, 2023
Arcens M, Noble S.
europepmc   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

ESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor, Willemijn A. van Maarschalkerwaart, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Eric H. Boersma, Loek van Heerebeek, Jasper J. Brugts, Robert M.A. van der Boon   +8 more
wiley   +1 more source

Diagnosis and treatment strategies for cardiogenic shock in Takotsubo syndrome with a temporary left ventricular assist device—A single-center study

JHLT Open
Background: Takotsubo syndrome (TTS) is a reversible form of acute heart failure characterized by apical ballooning, which may lead to cardiogenic shock (CS).
Anna Huang, Johanna K.R. von Mackensen, Vanessa I.T. Zwaans, Carla L. Schuering, Jasper Iske, Leonard Pitts, Julius Kaemmel, Gaik Nersesian, Cheng-Ying Chiu, Christoph T. Starck, Joerg Kempfert, Stephan Jacobs, Volkmar Falk, Evgenij V. Potapov, Leonhard Wert   +14 more
doaj   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Stress Cardiomyopathy as a Complication of SARS-CoV-2 Infection. [PDF]

Cureus, 2023
Rodrigues F, Flores R, Vilela MJ, Nogueira C, Raposo AR, Vieira C.   +5 more
europepmc   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Polimorfismi a Singolo Nucleotide e Cellule Progenitrici Endoteliali [PDF]

, 2010
Uno dei più interessanti target della ricerca clinica in campo cardiovascolare degli ultimi anni è rappresentato dalle Cellule Progenitrici Endoteliali (EPC).
ROVAI, GAIA
core